SCHEMBL5370186

SCHEMBL5370186

N#CC(Br)C(=O)c1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.50
PARP1 P09874 1/20 0.50
SLC6A2 P23975 5/20 0.49
SLC6A3 Q01959 4/20 0.49
CHRNA1 P02708 2/20 0.49
CHRNG P07510 2/20 0.49
CHRNB1 P11230 2/20 0.49
CHRNB2 P17787 2/20 0.49
CHRNB4 P30926 2/20 0.49
SLC6A4 P31645 2/20 0.49
CHRNA3 P32297 2/20 0.49
CHRNA4 P43681 2/20 0.49
CHRND Q07001 2/20 0.49
ITGA5 P08648 1/20 0.49
CYP2C19 P33261 1/20 0.49
HRH1 P35367 1/20 0.49
CHRNA7 P36544 1/20 0.49
OPRK1 P41145 1/20 0.49
KCNH2 Q12809 1/20 0.49
ALDH1A1 P00352 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529322 0.84 PARP1 (0.52) GSK3BPARP1SLC6A2SLC6A3CHRNA1
SCHEMBL3362673 0.82 PARP1 (0.57) GSK3BPARP1SLC6A2SLC6A3CHRNA1
SCHEMBL10898106 0.80 PARP1 (0.55) GSK3BPARP1SLC6A2SLC6A3CHRNA1
SCHEMBL28473881 0.80 PARP1 (0.55) GSK3BPARP1SLC6A2SLC6A3CHRNA1
SCHEMBL29848174 0.79 SLC6A2 (0.59) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL633225 0.79 SLC6A2 (0.59) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL8639727 0.79 PARP1 (0.53) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL10501628 0.78 HPGD (0.51) PARP1SMN1; SMN2CTSVCTSLCTSB
SCHEMBL19926137 0.78 KMT2A (0.50) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL395491 0.77 MDM2 (0.48) GSK3BPARP1CYP2C19HRH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186829-B1 Aryl-substituted heterocyclic enaminones BAYER AKTIENGESELLSCHAFT (DE) 2007-03-06 US disclosed
US-7186829-B1 Aryl-substituted heterocyclic enaminones BAYER AKTIENGESELLSCHAFT (DE) 2007-03-06 US disclosed
US-7186829-B1 Aryl-substituted heterocyclic enaminones BAYER AKTIENGESELLSCHAFT (DE) 2007-03-06 US disclosed
US-7049271-B2 Phenyl-substituted 2-enamino-ketonitriles BAYER AKTIENGESELLSCHAFT (DE) 2006-05-23 US disclosed
US-20060100106-A1 Phenyl-substituted 2-enamino-ketonitriles FISCHER REINER 2006-05-11 US disclosed
US-20060069253-A1 Aryl-substituted heterocyclic enaminones FISCHER REINER 2006-03-30 US disclosed
EP-1129071-B1 PHENYL-SUBSTITUTED CYCLIC ENAMINONES BAYER CROPSCIENCE AG (DE) 2005-10-26 EP disclosed
US-20030220196-A1 Phenyl-substituted-2enamino-keto nitriles BAYER AKTIENGESELLSCHAFT (DE) 2003-11-27 US disclosed
US-20030130125-A1 Phenyl-substituted cyclic enaminones FISCHER REINER (DE) 2003-07-10 US disclosed
EP-1286956-A1 PHENYL-SUBSTITUTED 2-ENAMINO-KETO NITRILES Bayer CropScience AG (DE) 2003-03-05 EP disclosed
EP-1259496-A1 (HETERO)ARYL-SUBSTITUTED HETEROCYCLIC ENAMINONES, PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES, ACARICIDES AND INSECTICIDES Bayer CropScience AG (DE) 2002-11-27 EP disclosed
US-6455472-B1 HERBICIDES, ACARICIDES, NEMATICIDES AND INSECTICIDES FOR CROPS BAYER AKTIENGESELLSCHAFT (DE) 2002-09-24 US disclosed
WO-2001085673-A1 PHENYL-SUBSTITUTED 2-ENAMINO-KETO NITRILES BAYER CROPSCIENCE AG (DE) 2001-11-15 WO disclosed
EP-1129071-A1 PHENYL-SUBSTITUTED CYCLIC ENAMINONES Bayer Aktiengesellschaft (DE) 2001-09-05 EP disclosed
WO-2001040202-A1 (HETERO)ARYL-SUBSTITUTED HETEROCYCLIC ENAMINONES, PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES, ACARICIDES AND INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-06-07 WO disclosed
WO-2000027812-A1 PHENYL-SUBSTITUTED CYCLIC ENAMINONES BAYER AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130125-A1 Phenyl-substituted cyclic enaminones DDT, CYP19A1, KCNA1 GSK3B 1661/4885PARP1 798/4885SLC6A2 3050/4885
US-20060069253-A1 Aryl-substituted heterocyclic enaminones DDT, NPY4R, NPY5R GSK3B 3876/4885PARP1 4630/4885SLC6A2 2803/4885
US-20060100106-A1 Phenyl-substituted 2-enamino-ketonitriles AR, KCNK4, KCNA1 GSK3B 1570/4885PARP1 2073/4885SLC6A2 2606/4885
US-20030220196-A1 Phenyl-substituted-2enamino-keto nitriles CYP1A1, CYP4X1, KCNK4 GSK3B 1964/4885PARP1 1858/4885SLC6A2 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.